Validation of the i-STAT handheld activated clotting time for use with bivalirudin

American Journal of Cardiology

Volumn 93, Issue 10, 2004, Pages 1318-1319

  Schussler, Jeffrey M ^a   Lander, Stuart R ^a   Wissinger, Laurie A ^a   Anwar, Azam ^a   Donsky, Michael S ^a   Johnson, Kenneth B ^a   Vallabhan, Ravi C ^a   Wischmeyer, Jason B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HIRULOG; THROMBIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DRUG EFFICACY; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; HEART CATHETERIZATION; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; POINT-OF-CARE SYSTEMS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 2342534949     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.076     Document Type: Article

References (12)

1. Schussler J.M., Aguanno J.J., Glover E.N., Vish N.A., Wissinger L.A., Schumacher J.R., Wheelan K.R. Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention. Am J Cardiol. 91:2003;464-466
2. Giraudeau B., Mary J.Y. Planning a reproducibility study how many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat Med. 20:2001;3205-3214
3. Bonett D.G. Sample size requirements for estimating intraclass correlations with desired precision. Stat Med. 21:2002;1331-1335
4. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics. 33:1977;159-174
5. Lee J.K., D Ong C.N. Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med. 19:1989;61-70
6. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention REPLACE-2 randomized trial. JAMA. 289:2003;853-863
7. Schussler J.M., Lander S.R., Johnson K.B., Vallabhan R.C. Bivalirudin in the cath lab a recovery area time analysis. Oral and poster presentations. Catheter Cardiovasc Interv. 59:2003;121-142
8. Erickson K.A., Wilding P. Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer. Clin Chem. 39:1993;283-287
9. Kisner H.J. i-STAT point-of-care blood analyzing system. Clin Lab Manag Rev. 7:1993;454-457
10. Bingham D., Kendall J., Clancy M. The portable laboratory an evaluation of the accuracy and reproducibility of i-STAT. Ann Clin Biochem. 36:1999;66-71
11. Gault M.H., Seymour M.E., Howell W.E. Evaluation of i-STAT creatinine assay. Nephron. 88:2001;178-182
12. Paniccia R., Fedi S., Carbonetto F., Noferi D., Conti P., Bandinelli B., Giusti B., Evangelisti L., Pretelli P., Palmarini M.F., Abbate R., Prisco D. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology. 99:2003;54-59